NO304026B1 - Forbindelser og produkter basert pÕ Amadori-reaksjoner samt fremgangsmÕte til fremstilling av bruk av samme - Google Patents

Forbindelser og produkter basert pÕ Amadori-reaksjoner samt fremgangsmÕte til fremstilling av bruk av samme

Info

Publication number
NO304026B1
NO304026B1 NO942930A NO942930A NO304026B1 NO 304026 B1 NO304026 B1 NO 304026B1 NO 942930 A NO942930 A NO 942930A NO 942930 A NO942930 A NO 942930A NO 304026 B1 NO304026 B1 NO 304026B1
Authority
NO
Norway
Prior art keywords
compounds
pct
group
aminoacid
deoxy
Prior art date
Application number
NO942930A
Other languages
English (en)
Norwegian (no)
Other versions
NO942930D0 (no
NO942930L (no
Inventor
Jan Zbigniew Mioduszewski
Krystyna Witkiewicz
Anna Inglot
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL29346492A external-priority patent/PL171023B1/pl
Application filed by Torf Ets filed Critical Torf Ets
Publication of NO942930D0 publication Critical patent/NO942930D0/no
Publication of NO942930L publication Critical patent/NO942930L/no
Publication of NO304026B1 publication Critical patent/NO304026B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
NO942930A 1992-02-13 1994-08-08 Forbindelser og produkter basert pÕ Amadori-reaksjoner samt fremgangsmÕte til fremstilling av bruk av samme NO304026B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL29346492A PL171023B1 (pl) 1992-02-13 1992-02-13 Sposób wytwarzania nowych induktorów cytokin
EP92103614 1992-03-03
PCT/EP1993/000327 WO1993016087A2 (en) 1992-02-13 1993-02-11 Amadori reaction compounds and products, process for their manufacture, and their use

Publications (3)

Publication Number Publication Date
NO942930D0 NO942930D0 (no) 1994-08-08
NO942930L NO942930L (no) 1994-08-08
NO304026B1 true NO304026B1 (no) 1998-10-12

Family

ID=26130822

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942930A NO304026B1 (no) 1992-02-13 1994-08-08 Forbindelser og produkter basert pÕ Amadori-reaksjoner samt fremgangsmÕte til fremstilling av bruk av samme

Country Status (21)

Country Link
US (1) US5723504A (bg)
JP (1) JPH07506344A (bg)
AT (1) ATE187734T1 (bg)
AU (1) AU672595B2 (bg)
BG (1) BG62172B1 (bg)
BR (1) BR9305878A (bg)
CA (1) CA2130106A1 (bg)
CZ (1) CZ285200B6 (bg)
DE (2) DE632813T1 (bg)
ES (1) ES2072244T1 (bg)
FI (1) FI943733A (bg)
GR (1) GR950300017T1 (bg)
HU (1) HUT70434A (bg)
MX (1) MX9300759A (bg)
NO (1) NO304026B1 (bg)
RO (1) RO115633B1 (bg)
RU (1) RU2141337C1 (bg)
SG (1) SG52390A1 (bg)
SK (1) SK86994A3 (bg)
TW (1) TW302368B (bg)
WO (1) WO1993016087A2 (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629412A (en) * 1994-07-11 1997-05-13 Glinskii; Guennadi V. Synthetic glycoamines that promote or inhibit cell adhesion
FR2746316B1 (fr) * 1996-03-19 1998-06-12 Guerlain Nouvelles compositions cosmetologiques ou dermatologiques
WO1997049389A1 (en) * 1996-06-27 1997-12-31 The Picower Institute For Medical Research 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced glycosylation endproducts and methods of use therefor
DE19705233A1 (de) * 1997-02-12 1998-08-13 Froelich Juergen C Verfahren zur Herstellung einer Formulierung enthaltend Arginin
GB0319463D0 (en) * 2003-08-20 2003-09-17 Givaudan Sa Compounds
TW200925268A (en) * 2007-12-06 2009-06-16 Mallinckrodt Baker Inc Fluoride-containing photoresist stripper or residue removing cleaning compositions containing conjugate oligomeric or polymeric material of alpha-hydroxycarbonyl compound/amine or ammonia reaction
JP2012140360A (ja) * 2010-12-28 2012-07-26 Kracie Home Products Ltd 抗酸化剤、化粧料、飲食品組成物及び医薬品組成物
JP5835894B2 (ja) * 2010-12-29 2015-12-24 クラシエホームプロダクツ株式会社 チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤、並びにこれらを含有する化粧料、飲食品組成物及び医薬品組成物
JP2012140378A (ja) * 2010-12-29 2012-07-26 Kracie Home Products Ltd チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤、並びにこれらを含有する化粧料、飲食品組成物及び医薬品組成物
JP2012140377A (ja) * 2010-12-29 2012-07-26 Kracie Home Products Ltd チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤、並びにこれらを含有する化粧料、飲食品組成物及び医薬品組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1514910A (en) * 1974-07-02 1978-06-21 Unilever Ltd Amadori compounds and their use to flavour foods
US4629692A (en) * 1982-12-06 1986-12-16 Miles Laboratories, Inc. Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia
DE3405841A1 (de) * 1984-02-17 1985-08-22 Bayer Ag, 5090 Leverkusen N-acylierte 1-alkylamino-1-desoxy-ketose-derivate, verfahren zur herstellung und ihre verwendung
DE3601472A1 (de) * 1986-01-20 1987-07-23 Fresenius Ag Verwendung von umsetzungsprodukten von reduzierenden zuckern und serotonin oder serotonin-precursoren zur behandlung cerebraler stoerungen
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater
WO1992016216A1 (en) * 1991-03-16 1992-10-01 Torf Establishment Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them

Also Published As

Publication number Publication date
HUT70434A (en) 1995-10-30
ES2072244T1 (es) 1995-07-16
DE69327310D1 (de) 2000-01-20
FI943733A0 (fi) 1994-08-12
NO942930D0 (no) 1994-08-08
RU2141337C1 (ru) 1999-11-20
SK86994A3 (en) 1995-02-08
GR950300017T1 (en) 1995-04-30
WO1993016087A2 (en) 1993-08-19
RU94040167A (ru) 1996-07-10
ATE187734T1 (de) 2000-01-15
CA2130106A1 (en) 1993-08-14
MX9300759A (es) 1993-11-01
US5723504A (en) 1998-03-03
DE632813T1 (de) 1996-02-15
HU9402347D0 (en) 1994-10-28
AU672595B2 (en) 1996-10-10
FI943733A (fi) 1994-08-12
RO115633B1 (ro) 2000-04-28
CZ194594A3 (en) 1994-12-15
CZ285200B6 (cs) 1999-06-16
BG62172B1 (bg) 1999-04-30
BG98956A (bg) 1995-07-28
WO1993016087A3 (en) 1993-09-16
AU3496693A (en) 1993-09-03
SG52390A1 (en) 1998-09-28
TW302368B (bg) 1997-04-11
BR9305878A (pt) 1997-08-19
JPH07506344A (ja) 1995-07-13
NO942930L (no) 1994-08-08

Similar Documents

Publication Publication Date Title
SE8703938D0 (sv) Peptide derivatives
PT1288223E (pt) Derivados de peptidos terapeuticos
RU95112539A (ru) Новый полипептид и фармацевтическая композиция против вич-инфекции
NO304026B1 (no) Forbindelser og produkter basert pÕ Amadori-reaksjoner samt fremgangsmÕte til fremstilling av bruk av samme
DE68927379D1 (de) Plättchen blockierende peptide
CA2208274A1 (en) Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
ES2138973T3 (es) Muteinas de il-6 exentas de cisteina.
DE3751398D1 (de) Substrat-Peptide.
KR890013061A (ko) 폴리펩티드 유도체
DE69133010D1 (de) Zur steigerung der antitumorimmunität wirksames proteoglykan (g009)
RU93043871A (ru) Ganoderma lucidum iv.009, продуцирующий протеогликан g 009, повышающий противоопухолевый иммунитет
EP0361956A3 (en) Increased expression of small molecular weight recombinant proteins
KR920011512A (ko) 항종양 면역증강효과가 있는 단백다당체(s 818)
RU93043842A (ru) Протеогликан g 009 - эффективный стимулятор противоопухолевого иммунитета
KR920011510A (ko) 항종양 면역증강효과가 있는 단백다당체(c 909)
KR920012421A (ko) 항종양 면역증강효과가 있는 단백다당체(S 818)를 생성하는 균주 쉬조필럼 콘뮨(Schizophyllum Commune) IY 818
MY102979A (en) Peptide derivatives
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция